title: The KCC3 cotransporter as a therapeutic target for peripheral neuropathy.
authors.affiliation: a Departments of Anesthesiology , Molecular Physiology & Biophysics, and Brain Institute, Vanderbilt University School of Medicine , Nashville , TN , USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Delpire
authors.affiliation: b Departments of Neurosurgery , Pediatrics and Cellular & Molecular Physiology; and Centers for Mendelian Genomics, Yale School of Medicine , New Haven , CT , USA.
authors.forename: Kristopher T
authors.initials: KT
authors.lastname: Kahle
mesh_terms: D000818:Animals; D006801:Humans; D051379:Mice; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology*; D027981:Symporters / Q000235:genetics / Q000378:metabolism*; D000096922:K Cl- Cotransporters
chemical_list: D027981:Symporters; C119650:SLC12A6 protein, human; D000096922:K Cl- Cotransporters; C492280:Slc12a6 protein, mouse
keywords: Bumetanide; KCC2; KCC3; KCl cotransporter; NKCC1; Na-K-2Cl cotransporter; SPAK/OSR1; WNK; cell swelling; cell volume regulation; furosemide